This study clearly demonstrates that extracellular supply of ADA enzyme through ERT results in ongoing metabolic abnormalities and associated defect in thymopoiesis, that are reflective of the suboptimal immune recovery in patients with ADA deficiency receiving long-term ERT. The gene discussed is ADA; the disease is hyperinsulinemic hypoglycemia, familial, 4.